Novadaq Technologies (NVDQ) 15.12 $NVDQ
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
NOVADAQ to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 -- Conference Call to Follow
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce its fourth quarter and full year 2014 financial results on Wednesday, February 25, 2015.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Participate in February Investor Conferences
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in February.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Look Past A Sales Transition To Novadaq's Future
Stephen Simpson, CFA - at Seeking Alpha - Fri Jan 16, 3:53PM CST
NVDQ: 15.12 (+0.51)
Novadaq Tech reports preliminary results and 2015 outlook
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:24PM CST
NVDQ: 15.12 (+0.51)
NOVADAQ Announces Fourth Quarter 2014 Preliminary Unaudited Revenues and Issues 2015 Revenue Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2014 and provided 2015 revenue guidance ahead of its participation at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 59.67 (+0.10), NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 29, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that its President and Chief Executive Officer, Dr. Arun Menawat, will present an update on the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 8:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA.
JPM: 59.67 (+0.10), NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
New finance chief at Novadaq
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 6:08AM CST
NVDQ: 15.12 (+0.51)
NOVADAQ Announces Organizational Changes to Support Continued Growth
GlobeNewswire - Mon Dec 22, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced various changes to its management team and structure designed to further position the Company for continued direct sales success and global growth.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Novadaq Technologies (NVDQ): Today's Weak On High Volume Stock
at The Street - Thu Dec 18, 9:04AM CST
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a weak on high relative volume candidate
NVDQ: 15.12 (+0.51)
Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 14.98 (+0.24), SPNC: 33.69 (-0.06), ABT: 46.09 (+0.87), PHG: 28.93 (-0.07), MDT: 75.26 (+0.33), TRIV: 10.07 (+0.15), VOLC: 17.98 (+0.03), STJ: 67.48 (+0.65), THOR: 40.01 (+0.54), HTWR: 88.18 (-0.09), ELGX: 14.51 (+0.21), ATRC: 18.86 (+0.04), NVDQ: 15.12 (+0.51)
Nasdaq stocks posting largest percentage increases
AP - Thu Dec 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SOFO: 8.07 (-0.16), NBIX: 37.22 (+0.27), DERM: 16.52 (-0.11), CHKE: 18.58 (+0.28), LAYN: 7.93 (+0.22), NDQ.TO: 18.80 (+1.02), CLDN: 16.45 (-0.05), NVDQ: 15.12 (+0.51), OBAS: 6.25 (-0.05)
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Soars 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:21AM CST
Novadaq Technologies Inc. (NVDQ) was a big mover last session, as the company saw its shares rise by over 17% on the day.
ETRM: 1.21 (+0.06), FLDM: 37.93 (-0.47), EW: 134.23 (+1.89), NVDQ: 15.12 (+0.51)
NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health's DermACELL Tissue Products
GlobeNewswire - Tue Dec 09, 4:17PM CST
Novadaq Technologies Inc. (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures and LifeNet Health, a world leader in allograft bio-implants and cellular therapies, today jointly announced the signing of a multi-year agreement pursuant to which, NOVADAQ was appointed exclusive worldwide distributor of LifeNet Health's DermACELL tissue products for wound and breast reconstruction surgery.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Novadaq Technologies wins additional SPY fluorescence technology patent protection in the US
M2 - Tue Dec 09, 6:23AM CST
Fluorescence imaging company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) reported on Monday the receipt of the Patent No. 8,892,190 entitled "Method and Apparatus for Performing Intra-Operative Angiography" in the US.
NVDQ: 15.12 (+0.51)
NOVADAQ Granted Additional SPY Technology Patent Protection in the U.S.
GlobeNewswire - Mon Dec 08, 4:12PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the recent grant of United States Patent No. 8,892,190 entitled "Method and Apparatus for Performing Intra-Operative Angiography." NOVADAQ's most recent U.S. Patent adds to the ever-increasing patent portfolio surrounding its SPY fluorescence imaging technology.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Participate in Piper Jaffray 26th Annual Healthcare Conference
GlobeNewswire - Tue Nov 25, 3:30PM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in a fireside chat presentation at the Piper Jaffray 26th Annual Healthcare Conference on Wednesday, December 3, 2014 at 11:30 a.m. Eastern Time at the Palace Hotel in New York, NY.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Novadaq Technologies (NVDQ) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:39AM CST
Novadaq Technologies (NVDQ) Shares March Higher, Can It Continue?
NVDQ: 15.12 (+0.51)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
NOVADAQ to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 -- Conference Call to Follow
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce its fourth quarter and full year 2014 financial results on Wednesday, February 25, 2015. NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Participate in February Investor Conferences
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in February. NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Look Past A Sales Transition To Novadaq's Future
Stephen Simpson, CFA - at Seeking Alpha - Fri Jan 16, 3:53PM CST
NVDQ: 15.12 (+0.51)
Novadaq Tech reports preliminary results and 2015 outlook
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:24PM CST
NVDQ: 15.12 (+0.51)
NOVADAQ Announces Fourth Quarter 2014 Preliminary Unaudited Revenues and Issues 2015 Revenue Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2014 and provided 2015 revenue guidance ahead of its participation at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. JPM: 59.67 (+0.10), NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 29, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that its President and Chief Executive Officer, Dr. Arun Menawat, will present an update on the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 8:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA. JPM: 59.67 (+0.10), NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
New finance chief at Novadaq
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 6:08AM CST
NVDQ: 15.12 (+0.51)
NOVADAQ Announces Organizational Changes to Support Continued Growth
GlobeNewswire - Mon Dec 22, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced various changes to its management team and structure designed to further position the Company for continued direct sales success and global growth. NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Novadaq Technologies (NVDQ): Today's Weak On High Volume Stock
at The Street - Thu Dec 18, 9:04AM CST
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a weak on high relative volume candidate
NVDQ: 15.12 (+0.51)
Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 14.98 (+0.24), SPNC: 33.69 (-0.06), ABT: 46.09 (+0.87), PHG: 28.93 (-0.07), MDT: 75.26 (+0.33), TRIV: 10.07 (+0.15), VOLC: 17.98 (+0.03), STJ: 67.48 (+0.65), THOR: 40.01 (+0.54), HTWR: 88.18 (-0.09), ELGX: 14.51 (+0.21), ATRC: 18.86 (+0.04), NVDQ: 15.12 (+0.51)
Nasdaq stocks posting largest percentage increases
AP - Thu Dec 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SOFO: 8.07 (-0.16), NBIX: 37.22 (+0.27), DERM: 16.52 (-0.11), CHKE: 18.58 (+0.28), LAYN: 7.93 (+0.22), NDQ.TO: 18.80 (+1.02), CLDN: 16.45 (-0.05), NVDQ: 15.12 (+0.51), OBAS: 6.25 (-0.05)
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Soars 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:21AM CST
Novadaq Technologies Inc. (NVDQ) was a big mover last session, as the company saw its shares rise by over 17% on the day.
ETRM: 1.21 (+0.06), FLDM: 37.93 (-0.47), EW: 134.23 (+1.89), NVDQ: 15.12 (+0.51)
NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health's DermACELL Tissue Products
GlobeNewswire - Tue Dec 09, 4:17PM CST
Novadaq Technologies Inc. (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures and LifeNet Health, a world leader in allograft bio-implants and cellular therapies, today jointly announced the signing of a multi-year agreement pursuant to which, NOVADAQ was appointed exclusive worldwide distributor of LifeNet Health's DermACELL tissue products for wound and breast reconstruction surgery.
NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Novadaq Technologies wins additional SPY fluorescence technology patent protection in the US
M2 - Tue Dec 09, 6:23AM CST
Fluorescence imaging company Novadaq Technologies (NasdaqGM:NVDQ) (TSX:NDQ.TO) reported on Monday the receipt of the Patent No. 8,892,190 entitled "Method and Apparatus for Performing Intra-Operative Angiography" in the US.
NVDQ: 15.12 (+0.51)
NOVADAQ Granted Additional SPY Technology Patent Protection in the U.S.
GlobeNewswire - Mon Dec 08, 4:12PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the recent grant of United States Patent No. 8,892,190 entitled "Method and Apparatus for Performing Intra-Operative Angiography." NOVADAQ's most recent U.S. Patent adds to the ever-increasing patent portfolio surrounding its SPY fluorescence imaging technology. NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
NOVADAQ to Participate in Piper Jaffray 26th Annual Healthcare Conference
GlobeNewswire - Tue Nov 25, 3:30PM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in a fireside chat presentation at the Piper Jaffray 26th Annual Healthcare Conference on Wednesday, December 3, 2014 at 11:30 a.m. Eastern Time at the Palace Hotel in New York, NY. NDQ.TO: 18.80 (+1.02), NVDQ: 15.12 (+0.51)
Novadaq Technologies (NVDQ) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:39AM CST
Novadaq Technologies (NVDQ) Shares March Higher, Can It Continue?
NVDQ: 15.12 (+0.51)
